Tong Chen

This publication record labeled 'Tong Chen' appears to combine work from multiple distinct researchers or groups, spanning cancer biology, immunology, nephrology, plant genetics, physics, and clinical medicine, so it does not represent a single coherent research program. Within the cancer-related subset, some work focuses on how tumor-supporting cells (cancer-associated fibroblasts) and RNA molecules influence breast cancer spread and treatment resistance, alongside broader studies on immune cells, kidney disease, and drug safety. Because the topics are so varied, prospective students should look closely at specific papers and co-author groups to identify the actual research focus rather than relying on this aggregated profile.

Publication output has grown substantially over the last decade, rising from under 20 papers per year in 2017-2018 to a peak of over 40 per year in 2022-2023, with continued high output (around 30-38 papers/year) through 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026